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Polyvinyl chloride (PVC) plastics are used
extensively for a very wide range of purposes,
such as interior surfaces, food wrappers, and
covering of crops in agriculture. Extensive use
of PVC is related to its stability and ﬂexibility,
which is achieved by incorporation of plasti-
cizers. More than 300 different types of plasti-
cizers have been identified, and between
50 and 100 are used commercially. Phthalates,
diesters of benzenedicarboxylic acid (phthalic
acids), constitute the most commonly used
plasticizers. In Western Europe, about 1 mil-
lion tons of phthalates are produced each
year, of which approximately 900,000 tons
are used to plasticize PVC (Plasticisers
Information Center 2007). The most com-
mon are diisononyl phthalate (DiNP),
diisodecyl phthalate (DiDP), and di-2-ethyl-
hexyl phthalate (DEHP).
Phthalate compounds leach, migrate, or
gas out from PVC-containing items into air,
dust, water, soils, sediments, and food and
have become ubiquitous environmental conta-
minants (Clark et al. 2003). Recent studies of
human urine samples in industrialized
countries have highlighted the large extent of
population exposure to various phthalates
(Wormuth et al. 2006). Diet, particularly fatty
food (e.g., dairy, ﬁsh, oils), is the main source
of DEHP exposure in the general public
(Clark et al. 2003; Meek and Chan 1994;
Peterson and Breindahl 2000; Wormuth et al.
2006); other sources include consumer prod-
ucts and medical procedures. Although phtha-
lates have low volatility, they off-gas and are
present in residential indoor air and dust
(Adibi et al. 2003; Rudel et al. 2003).
Dampness has been shown to enhance degra-
dation of PVC ﬂooring, resulting in elevated
indoor air concentrations of 2-ethyl-1-hexanol,
a hydrolysis product of DEHP (Norbäck et al.
2000; Tuomainen et al. 2004). Thus, although
most exposure to phthalates has traditionally
been thought to be ingestion, other routes—
such as dermal, parenteral, and, in particular,
inhalation—may be important. However, the
proportional contribution from various sources
and routes of exposure is unknown.
Evidence has accumulated for association
of harmful health effects with exposure to
phthalates, particularly DEHP (Hauser and
Calafat 2005), raising public concerns and
debates. Although emphasis has been given to
potential adverse reproductive and carcino-
genic effects, phthalates may have adverse
effects on airways and immunologic systems,
but the evidence has not been reviewed sys-
tematically. The objective of this study was to
review the evidence for the role of exposure to
phthalates from PVC products in the develop-
ment of asthma and allergies and to make
recommendations for future research.
Methods
Search strategy and inclusion criteria. We per-
formed a systematic literature search of the
Medline database (National Library of
Medicine, Bethesda, MD, USA) from 1950
through May 2007 using the search command
“[phthalates OR polyvinyl chloride] AND
[asthma OR allergy].” We identified and
screened a total of 54 references in two phases:
initially from abstracts, to eliminate the obvi-
ously irrelevant ones, and then from full publi-
cations of the remaining references. To be
included in the review, the study had to focus
on the effects of phthalate exposure on the
human respiratory system, or on an immuno-
logic parameter in animal or in vitro tests.
Data extraction. We divided the relevant
publications into three categories: mechanistic
toxicology studies, case reports and case series
on occupational asthma, and epidemiologic
studies and human controlled experiments.
From the epidemiologic study reports, we
recorded the most relevant characteristics of
each selected publication and considered the
possibility for its inclusion in the meta-analysis. 
Statistical methods. In the meta-analysis,
we calculated summary effect estimates by
using ﬁxed- and random-effects models. The
fixed-effects model applied the Mantel-
Haenszel method (Mantel and Haenszel 1959)
with inverse variances of individual effect esti-
mates as weights. The random-effects model
applied the method of DerSimonian and Laird
(1986). We calculated the natural log and its
SE for the effect estimates from the raw data or
from the conﬁdence intervals (CIs) presented
in the articles. When available, we preferred
the adjusted effect estimates over the crude
estimates. We used the “meta” command
Environmental Health Perspectives • VOLUME 116 | NUMBER 7 | July 2008 845
Review
Address correspondence to J. Jaakkola, Institute of
Occupational and Environmental Medicine,
University of Birmingham, Birmingham, B15 2TT
UK. Telephone: 44-121-4146023. Fax: 44-121-
4146217. E-mail: j.jaakkola@bham.ac.uk
Supplemental Material is available online at http://
www.ehponline.org/members/2008/10846/suppl.pdf
The authors declare they have no competing
ﬁnancial interests.
Received 5 September 2007; accepted 18 March
2008.
The Role of Exposure to Phthalates from Polyvinyl Chloride Products 
in the Development of Asthma and Allergies: A Systematic Review 
and Meta-analysis
Jouni J.K. Jaakkola and Trudy L. Knight
Institute of Occupational and Environmental Medicine, University of Birmingham, Birmingham, United Kingdom
BACKGROUND: Phthalates from polyvinyl chloride (PVC) plastics may have adverse effects on
airways and immunologic systems, but the evidence has not been reviewed systematically.
OBJECTIVE: We reviewed the evidence for the role of exposure to phthalates from PVC products in
the development of asthma and allergies.
Methods: We conducted a Medline database search (1950 through May 2007) for relevant studies
on the respiratory and allergic effects of exposure to phthalates from PVC products.
RESULTS: We based this review on 27 human and 14 laboratory toxicology studies. Two mouse
inhalation experiments indicated that mono-2-ethylhexyl phthalate (MEHP) has the ability to
modulate the immune response to exposure to a coallergen. The data suggested a no observed effect
level of 30 µg MEHP/m3, calculated to be below the estimated level of human exposure in common
environments. Case reports and series (n = 9) identiﬁed and veriﬁed cases of asthma that were very
likely caused by fumes emitted from PVC ﬁlm. Epidemiologic studies in adults (n = 10), mostly
small studies in occupational settings, showed associations between heated PVC fumes and asthma
and respiratory symptoms; studies in children (n = 5) showed an association between PVC surface
materials in the home and the risk of asthma [ﬁxed-effects model: summary odds ratio (OR), 1.55;
95% confidence interval (CI), 1.18–2.05; four studies] and allergies (OR, 1.32; 95% CI,
1.09–1.60; three studies).
CONCLUSIONS: High levels of phthalates from PVC products can modulate the murine immune
response to a coallergen. Heated PVC fumes possibly contribute to development of asthma in
adults. Epidemiologic studies in children show associations between indicators of phthalate expo-
sure in the home and risk of asthma and allergies. The lack of objective exposure information limits
the epidemiologic data.
KEY WORDS: allergy, asthma, phthalates, polyvinyl chloride. Environ Health Perspect 116:845–853
(2008). doi:10.1289/ehp.10846 available via http://dx.doi.org/ [Online 31 March 2008](Sterne et al. 2001) to run the ﬁxed- and ran-
dom-effects models on Stata 8.2 (StataCorp
LP, College Station, TX, USA). We tested
heterogeneity between study-specific effect
estimates using Q statistics and chi-square dis-
tribution (Sterne et al. 2001). The two meta-
analyses provided homogeneous results;
therefore, we did not need to elaborate deter-
minants of heterogeneity.
Results
Of the 54 publications we identified in the
Medline search, we eliminated 27 as obvi-
ously irrelevant. We retrieved copies of the
remaining 27 publications and reviewed them
in detail. We included an additional 14 refer-
ences cited in these articles that fulfilled our
inclusion criteria. We based the systematic
review on evidence from 41 publications,
which we categorized into mechanistic toxi-
cology studies (n = 14), case reports and case
series on occupational asthma (n = 9), epi-
demiologic studies (n = 17), and a human
controlled experiment (n = 1). 
Mechanistic toxicology studies. In the
Medline search, we identified eight publica-
tions categorized as mechanistic toxicology
(Butala et al. 2004; Doelman et al. 1990;
Glue et al. 2005; Hansen et al. 2007; Jepsen
et al. 2004; Larsen et al. 2001a, 2002, 2003),
and their reference lists yielded six additional
articles (Bally et al. 1980; Glue et al. 2002;
Klimisch et al. 1992; Larsen et al. 2001b,
2004; Nakamura et al. 2002). PubMed and
Toxline (National Library of Medicine)
searches for mechanistic studies identiﬁed no
additional studies articles.
Five articles described mechanistic studies
of a mouse model used to investigate whether
coadministration of a phthalate compound
modulates the immune response to an allergen
(ovalbumin) (Hansen et al. 2007; Larsen et al.
2001a, 2001b, 2002, 2003). In these studies
commercial plasticizers [diphthalates and butyl
benzyl phthalate (BBzP)] and their main
metabolites (monophthalates, phthalic acid,
and benzyl alcohol) were used as test com-
pounds. Formulas for common phthalates and
their metabolites are shown in Figure 1 [an
illustration of a metabolic scheme is presented
in Appendix Figure A, available online in
Supplemental Material (http://www.ehponline.
org/members/2008/10846/suppl.pdf); scheme
adapted from Fredericksen et al. 2007].
The initial studies (Larsen et al. 2001a,
2001b, 2002, 2003) were designed to investi-
gate whether phthalates have adjuvant or
immunosuppressive properties without consid-
ering true human exposure routes or concen-
trations. Compounds were administered by
subcutaneous injection: either a 100-µL dose
of a solution containing 1 µg ovalbumin and 0,
1, 10, 100, or 1,000 µg phthalate/mL (Larsen
et al. 2001a) or a 50-µL dose of a solution of
1 µg ovalbumin and 0, 2, 20, 200, or 2,000 µg
phthalate/mL (Larsen et al. 2001b, 2002,
2003). Responses were assessed by enzyme-
linked immunosorbant assay of IgE, IgG1,
and IgG2a antibodies. Stimulation of the
TH2 pathway, which is predominant in type I
allergies, involves increased production of IgE
and IgG1 antibodies, whereas stimulation of
the TH1 response, predominant in type IV
allergies, involves IgG2a antibodies (Larsen
et al. 2001a). A statistically significant
increase or decrease in antibodies, by phtha-
late, was defined as an adjuvant or an
immunosuppressive effect, respectively.
Individual phthalates varied in the anti-
body class they induced and in their potency of
adjuvancy. The concentrations of phthalates
that provoked a statistical increase in anti-
bodies in response to one booster of ovalbumin
were the monophthalates mono-2-ethylhexyl
phthalate (MEHP), 10 µg/mL (IgE); mono-n-
octyl phthalate (MnOP), 100 µg/mL (IgE) and
10 µg/mL (IgG); monoisononyl phthalate
(MiNP), 100 µg/mL (IgE) (Larsen et al.
2001a); and the diphthalates DEHP,
2,000 µg/mL (IgG1) (Larsen et al. 2001b); di-
n-butyl phthalate (DnBP), 200 µg/mL (IgG1);
DiNP, 200 µg/mL (IgE) and 200 µg/mL
(IgG1); di-n-octyl phthalate (DnOP),
2,000 µg/mL (IgG1) and 2,000 µg/mL (IgE)
(compared with the corresponding control
group; Larsen et al. 2002); and DiDP, 2,000
µg/mL (IgE) (compared with only the cumu-
lated ovalbumin control groups; Larsen et al.
2002). Mono-n-butyl phthalate (MnBP),
monobenzyl phthalate (MBnP) (Larsen et al.
2001a), and BBzP (Larsen et al. 2003) pro-
duced no adjuvancy. IgG2 antibodies were not
induced by any of the phthalates tested.
The extent of adjuvancy provoked by indi-
vidual phthalates was thus shown to be struc-
ture related (Jepsen et al. 2004; Larsen et al.
2001a). In mice, monophthalates with 8
(MEHP, MnOP) or with 9 (MiNP) side-chain
carbons caused a greater increase in antibodies
than those with 4 (MnBP), 7 (MBnP), or
10 [monoisodecyl phthalate (MiDP)] side-
chain carbons (Larsen et al. 2001a). In vitro
studies in a human epithelial cell line (Jepsen
et al. 2004) comparing the cytokine stimulation
potencies of monophthalates showed MEHP,
MnOP, and MiNP to be more potent inducers
of cytokines than MnBP or MBnP (Jepsen
et al. 2004); in contrast to the in vivo work,
MiDP was a potent inducer of cytokines.
The degree of increase (and sometimes the
class) of antibodies was generally shown to be
concentration dependent. For example,
DnOP produced a concentration-dependent
increase in production of IgG1 but not IgE
(Larsen et al. 2002). Exposure of mice to
200 µg/mL DiNP following a single booster
of ovalbumin produced non–concentration-
dependent increased levels of IgG1 and IgE;
however, after two boosters, a concentration-
dependent adjuvancy in IgG1, but no adju-
vancy in IgE, was observed (Larsen et al.
2002). Furthermore, increasing the concentra-
tion of some phthalates (DnBP and DiNP,
from 200 to 2,000 µg/mL) caused a decrease
in antibody production (Larsen et al. 2002).
Exposure of mice to benzyl alcohol, a metabo-
lite of BBzP, also caused a significant reduc-
tion in IgG1 release compared with that in
control mice given ovalbumin only (Larsen
et al. 2003).
Subsequent work in mice used the inhala-
tion route of administration to mimic human
exposure to airborne phthalates (Hansen et al.
2007; Larsen et al. 2004). Mice received long-
term exposures (20 min for 5 days/week for
2 weeks, then once weekly for 12 weeks) to
aerosols of ovalbumin with 0.03 or 0.4 mg
MEHP/m3 (Hansen et al. 2007). Although no
effects were observed on lung function para-
meters or in the levels of IgE or IgG2, the levels
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Figure 1. Chemical formulas of phthalates.
Basic structure of a phthalate compound Basic structure of a monophthalate compound
Phthalate compound No. side-chain carbons Formula Metabolite Formula
Dimethyl phthalate  1 C10H10O4 Monomethyl phthalate  C9H8O4
Di-n-butyl phthalate (DnBP) 4 C16H22O4 Mono-n-butyl phthalate (MnBP) C12H14O4
Di-isohexyl phthalate  6 C20H30O4 Monoisohexyl phthalate  C14H18O4
Di-2-ethylhexyl phthalate (DEHP) 8 C24H38O4 Mono-2-ethylhexyl phthalate (MEHP) C16H22O4
Di-n-octyl phthalate (DnOP) 8 C24H38O4 Mono-n-octyl phthalate (MnOP) C16H22O4
Di-isononyl phthalate (DiNP) 9 C26H42O4 Monoisononyl phthalate (MiNP) C17H24O4
Di-isodecyl phthalate (DiDP) 10 C28H46O4 Monoisodecyl phthalate (MiDP) C18H26O4
Dibenzyl phthalate  Aromatic ring C22H18O4 Monobenzyl phthalate (MBnP) C15H12O4















R,R1 = any alkyl groupof serum IgG1 and the number of lympho-
cytes and eosinophils in bronchoalveolar
lavage (BAL) ﬂuid were signiﬁcantly increased
by exposure to 0.4 mg MEHP/m3, relative to
those in the ovalbumin-only group (Hansen
et al. 2007). No modulation of immune
response was apparent after exposure to
0.03 mg MEHP/m3, and the group estab-
lished this as the no observed effect level
(NOEL) (Hansen et al. 2007) to assess the rel-
evance of their ﬁndings to normal exposures of
humans. They used the NOEL of MEHP
(0.03 mg/m3) to estimate the parent compound
(DEHP) equivalence (3 mg DEHP/m3); using
median indoor air and worst-case exposures of
0.04 µg and 1.2 µg DEHP/m3, they estimated
a margin of exposure (i.e., the ratio of no
effect concentration DEHP/human exposure
concentration DEHP) to be between 2,500
and 75,000 (Hansen et al. 2007). 
Larsen et al. (2004) measured indicators of
modulation of immune response to ovalbu-
min by MEHP after short-term exposures
(60 min; 0.3–43.6 mg/m3 dose). They
reported a concentration-dependent decrease
in tidal volume (NOEL ~ 300 µg/m3) and an
increased number of alveolar macrophages,
but no change in numbers of neutrophils,
lymphocytes, eosinophils, or epithelial cells in
BAL ﬂuid. By calculating a worst-case human
exposure value to DEHP (300 µg/m3) (using
on-ﬂoor and airborne dust levels in Oslo and
Denmark and personal air samples from
Poland) and extrapolation of ventilation rate
and lung surface area in mice to human para-
meters, this group concluded that no airway
irritation can be expected from indoor expo-
sure to DEHP in nonoccupational settings.
Phthalate compounds also showed an
immunosuppressive effect on the immune
response to ovalbumin in in vivo and in vitro
studies (Jepsen et al. 2004; Larsen et al.
2001a). NOEL values determined for these
effects (Jepsen et al. 2004; Larsen et al.
2001a) showed structure-related variation
between individual compounds (Larsen et al.
2001a). In general, the longer the carbon
chain, the lower the NOEL. The NOELs for
suppression of IgE and IgG1 for individual
monophthalates were 100 µg/mL (MEHP),
100 µg/mL (MnOP), 10 µg/mL (MiDP), and
100 µg/mL (MiNP, IgE) and 10 µg/mL
(MiNP, IgG1) (Larsen et al. 2001a). MnBP
and MBnP produced no immunosuppression
(Larsen et al. 2001a). Similarly, in vitro stud-
ies using human cell lines showed that MiDP,
MiNP, MEHP, and MnOP were more sup-
pressive of interleukin (Il)-6 and Il-8 than
were MBnP and MnBP (Jepsen et al. 2004)
and that, in most cases, the NOEL for sup-
pression was the same as the concentration
that induced maximum cytokine production.
For this group of articles (Jepsen et al.
2004; Larsen et al. 2002, 2003), laboratory
experiments in mice and human lung epithelial
cells showed a modulatory effect by phthalate
compounds on the immune response to a
coallergen. In general, lower concentrations of
phthalates showed adjuvancy, and higher con-
centrations showed immunosuppression
(Jepsen et al. 2004; Larsen et al. 2002, 2003).
The remaining mechanistic toxicologic
studies were of various cellular and physio-
logic aspects of immune response induced by
phthalates. In mice, Butala et al. (2004) used
topical administration of diphthalates [DEHP
(25%, 50%, and 100%), DiNP, BBzP, and
di-isohexyl phthalate (100%)], without
coallergen, to investigate their effects on levels
of serum IgE and lymph node cytokines (Il-4
and Il-13), as an indication of their respira-
tory sensitizing potential. The diphthalates
produced no significant increases in IgE or
cytokines, and Butala et al. (2004) concluded
that diphthalates have little, if any, respiratory
sensitizing potential. 
In vitro 24-hr incubation of a human
monocytic cell line (THP-1) with a dilution
series (0.2, 2.0, 20, and 200 µg/mL) of
MEHP, MnBP, or MBnP, or 48-hr incuba-
tion of human peripheral blood mononuclear
cells with 220 µg/mL MnOP, MiNP, or
MiDP produced no increased cytokine
responses (Glue at al. 2002). Bally et al.
(1980) reported an increase in phagocytosis
and release of lysosomal enzymes in rabbit
alveolar macrophages treated with DEHP in
concentrations comparable with those found
in stored blood. In rat basophilic leukemia
cells (RBL-2H3 mast cells), antigen-induced
degranulation (β-hexosaminidase release)
increased by raised cytosolic calcium ion con-
centration induced by coincubation with
phthalates (DnBP to a greater extent than
diisobutyl phthalate or DEHP) (Nakamura
et al. 2002). Glue et al. (2005) reported rapid
histamine release after incubation of human
peripheral blood mononuclear cells (contain-
ing 0.1–1% basophils) with DEHP or
MEHP, and anti-IgE antibody costimulant.
The 8-carbon phthalates (DEHP, MEHP,
MnOP, and DnOP) were the strongest hista-
mine release potentiators, whereas 4-, 9-, or
10-carbon phthalates (MnBP, DnBP, MiNP,
DiNP, MiDP, and DiDP) caused no or low
induction of histamine (Glue et al. 2005).
Alternative costimulants [formyl-methionyl-
leucyl-phenylalanine, a bacteria-derived pep-
tide; calcium ionophore; and cat hair extract)
also provoked increased release of histamine
compared with controls (Glue et al. 2005). In
rats, DEHP inhalation (estimated doses of
230, 11, or 2.3 mg/kg/day for males and 360,
18, or 3.6 mg/kg/day for females) resulted in
a signiﬁcant increase in relative lung weights
and increased foam cell proliferation and
thickening of the alveolar septi (Klimisch
et al. 1992). MEHP (0.1 mmol/L), but not
DEHP or phthalic acid (concentrations up to
1 mmol/L), induced hypersensitivity to
methacholine-induced contraction of rat tra-
cheal muscle (Doelman et al. 1990), an effect
that the authors suggested may result in clini-
cal bronchial hyperreactivity, characteristic of
asthma, if it occurred in humans. 
In summary, animal studies show the
potential of phthalate compounds to cause
modulation of the immune response, and
indicate the mechanism involved (Hansen
et al. 2007; Larsen et al. 2001a, 2001b, 2002,
2003, 2004). The NOEL suggested from
these studies (0.03 mg/m3 MEHP) is esti-
mated to be substantially higher than normal
human exposures (Hansen et al. 2007; Larsen
et al. 2004). Uncertainty remains, however,
regarding the potential human exposure to
PVC degradation products in occupational
settings. Published extrapolations of experi-
mental doses to human exposures suggest that
in vivo ﬁndings in mice have depended upon
higher exposures than those encountered by
humans in the environment (Hansen et al.
2007; Larsen et al. 2004). 
Case reports and case series. The primary
search identiﬁed eight articles on case reports
or case series related to PVC exposure
(Andrasch and Bardana 1976; Brunetti and
Moscato 1984; Butler et al. 1981; Cipolla et al.
1999; Lee et al. 1989; Moisan 1991; Muñoz
et al. 2003; Pauli et al. 1980), and the refer-
ences provided one more article (Sokol et al.
1973). The 29 cases described in these nine
articles are summarized in Appendix Table A,
available online in Supplemental Material
(http:// www.ehponline.org/members/2008/
10846/suppl.pdf).
Four case reports (Andrasch and Bardana
1976; Muñoz et al. 2003; Pauli et al. 1980;
Sokol et al. 1973) identiﬁed and veriﬁed cases
of asthma that are very likely caused by fumes
from hot-wire cutting of PVC ﬁlm or in com-
bination with fumes from thermoactivated
price labels. Strong work-related respiratory
symptoms have been shown to occur without
specific airway reactivity to these fumes
(Butler et al. 1981).
Other cases of occupational asthma have
been linked to exposure to a heated mixture
of PVC and DEHP in production of artiﬁcial
leather (Brunetti and Moscato 1984); fumes
from residential fire involving plastic lami-
nates, refrigerator components, wall cover-
ings, and synthetic drapery material (Moisan
1991); unheated PVC resin mixtures (Lee
et al. 1989); and dioctyl phthalate from work
with a conveyor belt for bottle stoppers
(Cipolla et al. 1999).
Epidemiologic studies. We identified
12 articles on relevant epidemiologic studies,
and an additional 5 from their reference lists,
totaling 17 articles (Tables 1 and 2): 10 arti-
cles on adults and 7 on children.
Phthalates, asthma, and allergies
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Table 1. Summary of the 10 epidemiologic studies on the relationships between exposure to phthalates and PVC materials and the risk of asthma, allergy, and related respiratory out-
comes in adults, Medline search from 1950 through May 2007.
Reference, location Study design Study population Exposure  Outcomes Results Comment
Polakoff et al. (1975),  Cross-sectional  17 meat wrappers: Inhalation exposure to Symptoms, signs Exposed had a higher prevalence of Frequency matching of
USA study 21 ofﬁce personnel  pyrolysis products of PVC based on questionnaire cough ever (47.1% vs. 23.8%), reference group but no
and store clerks as  ﬁlm; assessment based on information; pre- and work-related shortness of breath adjustment for potential
a reference group job category (meat wrappers postshift spirometry: (23.5% vs. 0%), wheezing (5.9% vs.  confounders
exposed) and questionnaire FVC, FEV1, PEF, FEF25, 0%), eye watering and itching
information FEF50, FEF75, FEF90 (17.6% vs. 9.5%), nasal and
pharyngeal symptoms (29.4% vs.
4.8%), allergies (11.8% vs. 9.5%),
and decline over shift in FEV1
(p < 0.05) and FEF50 (p < 0.05)
Falk and Portnoy (1976), Cross-sectional 145 meat wrappers; Inhalation exposure to Symptoms, signs based Symptom prevalences in exposed Frequency matching of
Houston, TX, USA study 150 checkers and  pyrolysis products of PVC on questionnaire vs. checkers and cutters: reference group but no
150 meat cutters as  ﬁlm; assessment based on information shortness of breath (16% vs. 4% adjustment for potential
a reference group job category and interview and 4%; p < 0.05), wheezing (12% confounders
information vs. 5% and 7%; NS), chest pain
(17% vs. 5% and 7%; p < 0.05),
bronchitis (31% vs. 19% and 13%
p < 0.01), pneumonia (36% vs. 
27% and 9%; NS), and pleurisy
(33% vs. 16% and 9%; p < 0.01)
Andrasch et al. (1976), Cross-sectional 96 meat wrappers Inhalation exposure to Symptoms and signs  69% had work-related respiratory, 77% of symptomatic
Portland, OR, USA study pyrolysis products of PVC based on questionnaire mucosal, or system symptoms; workers reported
ﬁlm; assessment based on information (response 3 of 11 workers developed a mean improvement on
job title (meat wrappers  rate, 58%); and on decrease of 25% in FEV1 after  weekends and during
exposed) and questionnaire bronchial provocation exposure to PVC fumes; 9 of 13  vacations; no adjustment
information test to PVC fumes and  workers developed a 49% decrease  for potential confounders
price-label adhesive  in FEV1 and 40% decrease in FVC after
fumes for 14 workers exposure to price-label adhesive fumes
Brooks and Vandervort  Cross-sectional 44 workers in retail  Inhalation exposure to Symptoms and signs  Exposed vs. reference: cough, 37% vs. Exposed attributed
(1977), Ohio, USA study food industry: 24  pyrolysis products of PVC based on questionnaire 10%; dyspnea, 29% vs. 10%; symptoms to PVC ﬁlm
exposed meat  ﬁlm and thermoactivated information, spirometry wheezing, 12% vs. 0%; asthma/ fumes rather than
wrappers; 20 ofﬁce  price-label adhesive fumes (FVC, FEV1, MMF, VC50, allergy, 17% vs. 5%; nasal symptoms,  price-label adhesive
workers and store  and VC25) 14% vs. 0%; no differences between  fumes; no adjustment for
clerks as a reference  pre- and postshift lung function tests potential confounders
group
Eisen et al. (1985),  Cohort study 83 workers in the retail Inhalation exposure to Change in FEV1 over  No difference in FEV1 change between Workers with asthma or
Boston, MA, USA food industry: 40  pyrolysis products of PVC time (mL/year)  the exposed and reference group; allergy may be more
exposed to hot-wire or ﬁlm; assessment based on interaction term “hot-wire exposure* susceptible; adjusted for
cool-rod fumes, and 43  job title: meat wrappers, asthma/allergy,” 76 mL/year,  age, smoking, and
as a reference group meat cutters, and  p < 0.06  asthma/allergy
delicatessen product
workers exposed
Markowitz (1989), Cohort study 86 ﬁreﬁghters: 66  Exposed to burning PVC at  Occurrence and severity Exposed scored signiﬁcantly higher for  No adjustment for
Plainﬁeld, NJ, USA exposed, 20 as a  a warehouse ﬁre of respiratory symptoms  all symptoms after 5–6 weeks and  potential confounders
reference group based on questionnaire  all except wheeze after 22 months
information: cough, 
wheeze, shortness of 
breath, and chest pains 
5–6 weeks and 22
months after exposure
Nielsen et al. (1989),  Cross-sectional 39 workers in a PVC Exposed to PVC thermal Symptoms, signs based  Exposed vs. reference: conjunctivitis, Adjustment for age,
Denmark study processing plant: 20  degradation products and on questionnaire  25% vs. 0% (p < 0.02); rhinitis, 20% height, and smoking
exposed employed as  phthalic acid esters information, bronchial  vs. 10%; unspeciﬁc bronchial habits
machine attendants  provocation test, speciﬁc  hyperreactivity, 25% vs. 5%; dry
and calendar operators,  serum IgGs and IgEs,  cough, 45% vs. 0% (p < 0.001);
19 unexposed spirometry (VC, FEV1,  asthma, 10% vs. 0%; one positive
FEF50, FEF75)  reaction in bronchial provocation; 
one exposed had IgG against phthalic
anhydride; no differences in lung 
function parameters 
Norbäck et al. (2000),  Cross-sectional 87 workers in four  Two exposed buildings with Doctor-administered Exposed (yes/no): asthma symptoms, Adjusted for sex, age,
Sweden study hospitals: 50 residing  signs of dampness-related questionnaire  AOR, 8.6 (95% CI, 1.3–56.7) atopy, current smoking,
in exposed buildings  degradation of DEHP in on presence of  building dampness at
and 37 residing in  PVC ﬂooring and presence  asthma symptoms,  home and at work
reference buildings of 2-ethyl-1-hexanol in  wheezing, and/or 
indoor air; two reference  attacks of 
buildings breathlessness
Tuomainen et al. (2004),  Repeated cross- Ofﬁce building with 148 Before intervention: damp  Questionnaire  Index ofﬁce vs. national rates: eight  Intervention included
Finland sectional study  workers: ﬁrst survey,  and damaged PVC ﬂooring, information on  new cases of asthma in 4 years, 9.2  removal of ﬂoor 
before and after  92 participants; second 1–3 µg 2-ethyl-1-hexanol  symptoms and  times more than expected coverings, adhesives,
intervention survey, 115 participants per cubic meter of air perceived air quality and smoothing layers 
Jaakkola et al. (2006),  Population-based 521 new cases of asthma  Questionnaire information  Standardized clinical Asthma AOR (95% CI): plastic wall Adjusted for sex, age,
southern Finland incident case– (21–63 years of age),  on presence of plastic wall diagnosis of asthma materials at work, < 50% surface education, smoking, ETS,
control study and 932 population paper and ﬂooring in the based on history, vs. none, 1.26 (0.49–3.22);  other surface materials
controls home bronchial challenge, ≥ 50% surface vs. none,   at home and at work
and PEF monitoring 2.43 (1.03–5.75); PVC ﬂooring 
at work, 1.13 (0.84–1.51)
Abbreviations: AOR, adjusted OR; ETS, environmental tobacco smoke; FEF50, forced expiratory ﬂow at 50% of vital capacity; FEF75, forced expiratory ﬂow at 75%; FEF90, forced expiratory ﬂow at 90%; FEV1, forced expiratory
ﬂow in 1 sec; FVC, forced vital capacity; MMF, maximal midexpiratory ﬂow; NS, not signiﬁcant; PEF, peak expiratory ﬂow; VC, vital capacity; VC50, 50% vital capacity; V25, 25% vital capacity.Adult studies. All 10 studies in adults
assessed the relationship between PVC-related
occupational exposure (meat wrappers, hospi-
tal and office workers, firefighters, PVC
processors) and the risk of asthma, allergies, or
related respiratory effects (Andrasch et al.
1976; Brooks and Vandervort 1977; Eisen
et al. 1985; Falk and Portnoy 1976; Jaakkola
et al. 2006; Markowitz 1989; Nielsen et al.
1989; Norbäck et al. 2000; Polakoff et al.
1975; Tuomainen et al. 2004), and one of the
studies (Jaakkola et al. 2006) also examined
the role of home exposures. Of these studies,
6 were cross-sectional, and 4 were longitudi-
nal; 1 was a repeated cross-sectional study,
2 were cohort studies, and 1 was a population-
based incident case–control study.
Four of the cross-sectional studies
(Andrasch et al. 1976; Brooks and Vandervort
1977; Falk and Portnoy 1976; Polakoff et al.
1975) and one cohort study (Eisen et al. 1985)
assessed the relationship between PVC-fume
exposure in individuals employed as meat
wrappers and respiratory symptoms and ill-
nesses. Polakoff et al. (1975) published the ﬁrst
epidemiologic study on respiratory effects
related to meat wrapping. In that study,
17 meat wrappers exposed to pyrolysis prod-
ucts of PVC had a higher prevalence of cough,
phlegm, hay fever, and asthma than did the
reference group of 21 subjects (Table 1). The
exposed group also demonstrated relative
decreases in forced expiratory volume in 1 sec
(FEV1) and forced expiratory flow 50%
(FEF50) after one shift of work. Falk and
Portnoy (1976) conducted a cross-sectional
study of 445 Houston supermarket workers,
comparing two reference groups (150 checkers
and 150 meat cutters) with 145 meat wrappers
exposed to thermal decomposition fumes of
PVC film wrap. They reported an increased
prevalence of respiratory symptoms, including
shortness of breath, wheezing, and chest pain,
among the meat wrappers, as well as increased
occurrence of upper respiratory symptoms (dry
or sore throat, stuffy or runny nose, coughing,
chest tightness) and eye symptoms (burning,
itchy, or tearing eyes) and acute respiratory
tract illness (pleurisy, bronchitis, and pneumo-
nia) (Table 1). In a study of 96 meat wrappers
(Andrasch et al. 1976), 69% were reported to
present work-related effects of the respiratory
tract, mucous membranes, and systemic symp-
toms, with prevalences of 57%, 61%, and
16%, respectively. In bronchial provocation
tests of symptomatic workers to PVC fumes,
3 of 11 developed a mean decline of 25% in
FEV1. Exposure to adhesive fumes from price
labels resulted in a mean decline of 49% in
FEV1 and 40% in forced vital capacity (FVC)
of prechallenge values in 9 of 13 workers. In a
study of 24 meat wrappers and 20 ofﬁce clerks,
Brooks and Vandervort (1977) reported an
increased prevalence of asthma/allergy and
upper and lower respiratory tract symptoms
among exposed meat wrappers, but no differ-
ences were found between preshift and post-
shift lung functions. Eisen et al. (1985)
assessed pulmonary function before, during,
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Table 2. Summary of the ﬁve epidemiologic studies (in seven articles) on the relations between exposure to phthalates and PVC materials and the risk of asthma, allergy, and related
respiratory outcomes in children: Medline search from 1950 through May 2007.
Reference, location Study design Study population Exposure  Outcomes Results Comment
Jaakkola et al. (1999),  Cohort-based Children 0–2 years of  Blinded investigator  Case deﬁned as two or AOR (95% CI): PVC ﬂooring, Adjustment for other
Oslo, Norway matched case– age: 251 cases of  assessment: presence of  more episodes with yes/no, 1.89 (1.14–3.14); PVC surface materials, sex,
control study bronchial obstruction PVC ﬂooring and a symptoms and signs of index, Q3 vs. Q2 & Q1, 1.34 parental atopy, having
and 251 one-to-one  quantitative PVC index bronchial obstruction or (0.78–2.30); PVC index, Q4 vs. Q2 siblings, daycare
matched controls (range, 0–8)  one episode lasting  & Q1, AOR, 2.71 (1.50–4.91) attendance, breast-feeding, 
> 1 month exposure to ETS, dampness 
problems, maternal 
education, family income
Øie et al. (1999), Cohort-based Children 0–2 years of  Air change measurements; Case deﬁned as two or  AOR (95% CI), PVC index > 75th Adjustment for sex, parental
Oslo, Norway case–control  age: 172 cases of  low air change rate of  more episodes with percentile: low air change,  atopy, having siblings,
study bronchial obstruction  < 0.5/hr symptoms and signs 12.6 (1.00–159); high air  daycare attendance,
and 172 one-to-one  of bronchial obstruction change, 2.6 (1.02–6.58) breast-feeding, exposure
matched controls  or one episode lasting  to ETS, dampness
> 1 month problems
Jaakkola et al. (2000),  Population-based 2,568 children  Questionnaire information Questionnaire information AOR (95% CI), plastic wall material Adjusted for sex, age, 
Espoo, Finland cross-sectional  1–7 years of age on presence of plastic on the presence of  (yes/no): asthma, 1.52 (0.35–6.71); highest parental education, 
study wall or ﬂooring material in  asthma, allergic rhinitis, rhinitis, 1.20 (0.36–3.97); wheeze, single guardian, daycare
the home respiratory symptoms, 3.42 (1.13–10.4); cough, 2.41 center attendance, pets, 
infections (1.04–5.63); phlegm, 2.76 (1.03–7.41);  ETS, dampness 
nasal congestion, 0.95 (0.33–2.71);  problems
nasal excretion, 0.90 (0.32–2.57)
Bornehag et al. (2004a,  Population-based 10,851 children  Questionnaire information Questionnaire information AOR (95% CI) for PVC ﬂooring (yes/ Evidence of an interaction
2004b), Varmland, Sweden cross-sectional  1–6 years of age  on presence of PVC,  on doctor-diagnosed no): asthma, 0.98 (0.77–1.24); between PVC ﬂooring and
study dampness, and mold asthma, rhinitis and rhinitis, 1.09 (0.91–1.30) water leakage on asthma;
problems respiratory symptoms For water leakage (yes/no),   adjusted for sex, age,
asthma,1.23 (0.96–1.58);   allergic symptoms in
rhinitis, 1.35 (1.12–1.62)  family, smoking in
For PVC and leakage (yes/no), household
asthma, 1.48 (1.11–1.98); 
rhinitis, 1.22 (0.96–1.55)
Bornehag et al. (2004b),  Population-based 198 cases of persistent Trained investigator Baseline and 2-year Q4 vs. Q1, AOR (95% CI)  Adjusted for sex, age,
Varmland, Sweden prevalent case– asthma, rhinitis, or assessment of PVC follow-up surveys;  BBzP concentration for asthma,  smoking at home, type of
control study eczema and 202 popu- ﬂooring and bedroom medical examination  1.87(0.92–3.81); rhinitis, 3.04 building, construction
lation controls; 106 dust concentrations of and case veriﬁcation (1.34–6.89); eczema, 2.56 period, ﬂooding
asthma and 79 rhinitis  DEHP, BBzP, and four (1.24–5.32); 
cases and 177 controls other phthalates DEHP for asthma: 
AOR  (95% CI), 2.93 (1.36–6.34); 
rhinitis, COR,1.55 (0.73–3.28); 
eczema, COR, 1.50 (0.76–2.96)
Jaakkola et al. (2004),  Cross-sectional 5,951 children   Questionnaire information Questionnaire information AOR (95% CI), “linoleum”/ Adjustment for age, sex,
nine cities, Russia study 8–12 years of age  on recent installation of  on current asthma,  PVC ﬂooring (yes/no): past  preterm birth, low birth
surface materials and  current wheezing, 12 months for asthma, 1.13 (0.44– weight, parental atopy,
furniture any allergy 2.04); wheeze, 1.36 (1.00–1.86);  maternal smoking in
allergy, 1.31 (1.05–1.65) pregnancy, exposure to
Earlier for asthma, 1.39 (0.67–2.77); ETS, mother’s and
wheeze, 1.21 (0.99–1.59); allergy, father’s education
1.22 (1.04–1.45)
Abbreviations: AOR, adjusted OR; COR, corrected OR; ETS, environmental tobacco smoke; Q, quartile. and after shift in 83 workers in the retail food
industry; 40 workers using hot-wire wrapping
and exposed to PVC emissions were compared
with 43 workers not using hot-wire wrapping.
They found no association between acute
FEV1 change and hot-wire wrapping, but the
interaction term for hot-wire exposure and
asthma/allergy was borderline signiﬁcant, sug-
gesting that workers with asthma or allergy
may constitute a susceptible group.
Of these epidemiologic studies, all provide
evidence for a high prevalence of work-related
eye and upper and lower respiratory tract
symptoms among meat wrappers. Those stud-
ies conducted with a suitable reference group
show that the risk is substantially higher
among the exposed (Table 1). The ﬁndings on
the effects on lung function were inconsistent;
Polakoff et al. (1975) found an increased
preshift–postshift decline in FEV1 and FEF50,
whereas Brooks and Vandervort (1977) found
no changes in any of the studied lung function
parameters. Eisen et al. (1985) found no gen-
eral longitudinal decline over time but pro-
vided evidence of such an effect among
workers with asthma or allergy.
Two additional epidemiologic studies pro-
vide evidence that pyrolysis products of PVC
may increase bronchial reactivity and asthma
symptoms. In a cohort study, Markowitz
(1989) reported that 66 ﬁreﬁghters exposed to
burning PVC at a warehouse fire had an
increased risk of asthma-related respiratory
symptoms 5–6 weeks and 22 months after the
exposure. In a study of 39 PVC-processing
plant workers, Nielsen et al. (1989) found that
machine attendants exposed to PVC thermal
degradation products and phthalic acid esters
had a higher prevalence of asthma, rhinitis,
and eye and respiratory symptoms than did an
internal, unexposed reference group. One of
20 exposed workers had a positive specific
bronchial provocation test, and 1 had speciﬁc
IgG against phthalic anhydride.
Three epidemiologic studies assessed the
potential role of PVC surface materials and the
development of asthma, allergies, and related
health problems (Jaakkola et al. 2006; Norbäck
et al. 2000; Tuomainen et al. 2004). Norbäck
et al. (2000) studied 87 workers in four
Swedish geriatric hospitals. Two hospitals had
signs of dampness-related degradation of
DEHP in PVC flooring, indicated by visual
observations and indoor air measurement of
2-ethyl-1-hexanol, a hydrolysis product of
DEHP. The risk of asthma symptoms was
greater among the 50 exposed workers than
among the 37 workers in the two reference
hospitals, with an adjusted odds ratio (OR) of
8.6 (95% CI, 1.3–56.7). Tuomainen et al.
(2004) identiﬁed an ofﬁce building with severe
dampness problems and damaged PVC ﬂoor-
ing that had indoor air 2-ethyl-1-hexanol con-
centrations of 1–3 µg/m3. They conducted a
repeated cross-sectional study of the workforce
before and 4 years after the intervention, which
included removal of ﬂoor coverings, adhesive,
and smoothing layers. The prevalence of respi-
ratory, conjunctival, and nasal symptoms was
reduced after the intervention. Eight new cases
of asthma occurred during a 4-year period,
which is 9.2 times more than expected. In
another study, Tuomainen et al. (2006) con-
ducted controlled challenge tests using
degraded PVC products in 10 workers who
had previously experienced respiratory symp-
toms related to this ofﬁce building, 5 of which
had doctor-diagnosed asthma (Tuomainen
et al. 2006). After the challenge, they found a
50% increase in the number of symptoms
reported compared with 0% before the chal-
lenge (p < 0.029); the challenge did not inﬂu-
ence the lung function parameters, exhaled
nitrous oxide (NO), nasal NO, or NO in nasal
lavage. The exhaled samples contained 2-ethyl-
1-hexanol. In a population-based incident
case–control study of 521 new asthma cases
and 932 population controls (Jaakkola et al.
2006), the risk of asthma was related to the
presence of plastic wall materials at work
(< 50% wall surface: adjusted OR, 1.26;
95% CI, 0.49–3.22; ≥ 50% wall surface:
adjusted OR, 2.43; 95% CI, 1.03–5.75) com-
pared with no plastic materials. 
Studies in children. The systematic search
identified seven articles from five epidemio-
logic studies conducted in Norway (Jaakkola
et al. 1999; Øie et al. 1999), Finland (Jaakkola
et al. 2000), Sweden (Bornehag et al. 2004a,
2004b, 2005), and Russia (Jaakkola et al.
2004), with each article providing effect esti-
mates on the relationship between residential
exposure to PVC-related emissions and the risk
of asthma, allergies, or related respiratory
effects (Table 2). The Finnish (Jaakkola et al.
2000) and the Russian studies (Jaakkola et al.
2004) and the ﬁrst phase of the Swedish study
(Bornehag et al. 2004a, 2005) were popu-
lation-based cross-sectional studies. The
Norwegian study (Jaakkola et al. 1999; Øie
et al. 1999) was a one-to-one matched case–
control study, and the second phase of the
Swedish study (Bornehag et al. 2004b) was a
case–control study. The cross-sectional studies
based both exposure and outcome assessment
on parent-administered questionnaire informa-
tion. Both case–control studies (Bornehag et al.
2004b; Jaakkola et al. 1999) used trained
investigators to assess the sources of exposure
and other residential factors; in addition, the
Swedish study (Bornehag et al. 2004b) mea-
sured content of six phthalates in the dust sam-
ples taken from the child’s bedroom. In the
Norwegian study, Jaakkola et al. (1999) based
the assessment of bronchial obstruction on
information from the project pediatrician, fam-
ily physician records, follow-up questionnaires,
and medical records. They deﬁned bronchial
obstruction as two or more episodes of symp-
toms and signs of bronchial obstruction or one
episode lasting > 1 month. A committee of
three senior pediatricians made the ﬁnal deci-
sion. In the Swedish case–control study
(Bornehag et al. 2004b), the cases were deﬁned
as individuals reporting two of three conditions
during the past 12 months, including at least
two incidents of eczema, or wheezing, or rhini-
tis without a cold and, in the 1.5-year follow-
up, at least two of three possible symptoms or
conditions. The cases and controls underwent
a medical examination.
In the Norwegian matched case–control
study of 251 cases of bronchial obstruction and
251 controls (Jaakkola et al. 1999), the risk of
bronchial obstruction was greater in the pres-
ence of PVC in the ﬂoors (adjusted OR, 1.89;
95% CI, 1.14–3.14). The risk of bronchial
obstruction was also related to a plasticizer
exposure index (adjusted OR, 2.72; 95% CI,
1.50–4.91). Further analyses showed that the
relationship of bronchial obstruction to a plas-
ticizer exposure index was stronger in homes
with low air change than in those with high air
change (Øie et al. 1999).
In the Finnish population-based cross-
sectional study of 2,568 children 1–7 years of
age, the risks of wheezing, persistent phlegm,
weekly nasal congestion or excretion, and res-
piratory infections were related to the presence
of plastic wall materials at home (Jaakkola
et al. 2000).
In the Swedish cross-sectional study of
10,851 children (Bornehag et al. 2004b), the
risks of asthma, rhinitis, wheezing, or cough
past 12 months of age were not related to the
presence of PVC ﬂooring when adjusting for
personal, family, and housing characteristics
(ORs, 0.90–1.15). Water leakage and other
indicators of dampness and mold problems
were independent determinants of asthma and
rhinitis. However, the combination of water
leakage and the presence of PVC ﬂooring was
the strongest determinant of doctor-diagnosed
asthma (adjusted OR, 1.48; 95% CI,
1.11–1.98) and rhinitis (adjusted OR, 1.38;
95% CI, 1.15–1.65), compared with no leak-
age and PVC ﬂooring. Bornehag et al. (2004b)
conducted a case–control study on a population
recruited from a 1.5-year follow-up of the cross-
sectional study. The 198 cases included subjects
with persistent allergic symptoms present both
at baseline and on follow-up surveys (106 with
asthma, 79 with rhinitis, and 115 with eczema),
and 202 controls were free of these symptoms.
The cases and controls underwent a medical
examination, and a trained technician assessed
the characteristics of their homes. The case sta-
tus was related to the presence of PVC ﬂooring
in the bedroom (adjusted OR, 1.59; 95% CI,
1.05–2.41). The dust concentrations (milli-
grams per gram dust) of six phthalates—diethyl
phthalate, di-isobutyl phthalate, DnBP, BBzP,
Jaakkola and Knight
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house dust concentrations of BBzP were higher
in the bedrooms of cases (0.899 mg/g dust)
than in those of controls (0.723 mg/g dust).
The risk of allergic rhinitis and eczema was
related to the house-dust BBzP concentrations,
whereas the risk of asthma was related to the
concentration of DEHP (Bornehag et al.
2004b).
Four studies provided comparable esti-
mates of the relation between presence of
PVC surface materials and the risk of asthma,
and three studies focused on allergic rhinitis
or allergies. This enabled two formal meta-
analyses. In the ﬁxed-effects model, the sum-
mary OR of asthma was 1.55 (95% CI,
1.18–2.05), and the study-speciﬁc effect esti-
mates were homogeneous [Q statistic
(3 degrees of freedom), 1.701; p = 0.637]. The
summary OR of allergic rhinitis was 1.32
(95% CI, 1.09–1.60), again with homo-
geneous study-speciﬁc effect estimates [Q sta-
tistic (2 degrees of freedom), 0.236; p = 0.902].
Discussion
From public and occupational health perspec-
tives, it is important to address whether the
inclusion of plasticizers in household goods
and their occurrence in common environ-
ments increase risk of asthma and allergies to
the public and to certain employees. There are
two relevant scientific questions: a) Can
phthalates, particularly DEHP and its metabo-
lites, cause immunologic effects leading to an
increased risk of asthma and allergies? b) Are
phathalate levels encountered in common and
occupational environments sufficient for
increasing the risk of asthma and allergies?
Validity of results. We selected the studies
using a clearly deﬁned search strategy. We also
used secondary references cited by the articles
identiﬁed in the primary search. Two observers
independently checked the eligibility of the
studies according to an a priori set of criteria.
The small number of studies in the meta-
analyses did not allow any formal assessment of
potential publication bias; that is, there is a
possibility that manuscripts with positive ﬁnd-
ings were more likely to be published than
those with negative ﬁndings. Also, some valid-
ity issues were common to all epidemiologic
studies because of the nature of the study ques-
tions. There was a possibility of confounding if
some known or unknown determinants of
asthma and/or allergies were related to presence
of PVC surface materials or phthalates in the
environments of interest. All the epidemiologic
studies in children adjusted for several poten-
tial confounders, as shown in Table 2, but
there could also be some residual confounding.
Dampness and mold problems in conjunction
with PVC materials are a complex issue. There
is evidence that dampness enhances both
microbial growth and degradation of PVC
materials, both of which are potential determi-
nants of asthma. The Swedish case–control
study (Bornehag et al. 2005) showed an
association between PVC materials and asthma
and allergies, mainly in the presence of damp-
ness problems. This could mean that dampness
is needed for any relevant emissions from PVC
materials and/or for dampness-induced micro-
bial growth and PVC degradation products to
interact in causing asthma and allergies. All the
epidemiologic studies included in the meta-
analyses adjusted for dampness and mold prob-
lems (Table 2), and therefore, dampness
problems are not likely to confound the
observed relationship between PVC and/or
phthalates. The role of interaction cannot be
properly addressed with the present data.
Causal inference. Figure 2 presents a
framework for causal inference by illustrating
a relevant source–emission–concentration–
exposure–effect pathway, which is useful for
judging the weight of evidence and need for
further research. The ﬁrst challenge in causal
inference is the identification of the specific
agent(s). Øie et al. (1997) hypothesized that
MEHP, the primary hydrolysis product of
DEHP, could serve as a speciﬁc causal agent.
They proposed that MEHP, the primary
hydrolysis product of DEHP, mimics the
inducing prostaglandins (PG) PGD(2),
9α,11βPGF2, and PGF2α and thrombox-
anes in the lungs, thereby increasing the risk
of inducing inflammation in the airways,
which is a characteristic of asthma.
Laboratory studies have shown that many
phthalate compounds administered to mice by
subcutaneous injection (Larsen et al. 2001a,
2001b, 2002) or by inhalation (Hansen et al.
2007) exert an adjuvant effect on the immune
response to exposure to a coallergen. The
extent of increased response appeared to be
associated with the length of the carbon chain
(Larsen et al. 2001a). The inhalation studies
mimicked the human route of exposure to air-
borne phthalates and provided a measure of
NOEL (0.03 mg MEHP/m3) (Hansen et al.
2007). This NOEL was calculated to exceed
levels encountered in common environments
as described by Larsen et al. (2004) and
Hansen et al. (2007), and also by Larsen et al.
(2007), which was published since the cutoff
date for our literature search and thus was not
included in the systematic review.
Ideally, we should have knowledge of
sources and emission rates of phthalates in
real-life conditions, concentration measure-
ments preferably at human breathing zones,
and biomarkers of exposure. Also required are
exposure–effect relation studies, which use
appropriate measures of exposures and deﬁned
outcomes, such as an immunologic parameter
or clinical sign. Present knowledge, though
sparse, is summarized below, highlighting
areas that require investigation to enable a
rational approach to further research.
Sources. Although the main source of
exposure for DEHP and other phthalates in
the general population is diet (Clark et al.
2003; Meek et al. 1994; Peterson et al. 2000;
Wormuth et al. 2006), PVC materials in the
environment constitute an important source
for inhalational exposure. Several million tons
of phthalates are used each year worldwide in
the production of PVC and other plastics. For
example, the use of DEHP in Europe in 1997
is estimated at 476,000 tons, of which about
Phthalates, asthma, and allergies
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Figure 2. A framework for causal inference illustrating a relevant source–emission–concentration–
exposure–effect pathway. 

































bronchial reactivity97% is used as plasticizer in polymers, mainly
PVC (European Chemicals Bureau 2006), for
use in outdoor products (about 22%) or
indoor products (462,000 tons). The typical
concentration of DEHP in plasticized PVC is
30% (RAR 2006). Thus, sources of the phtha-
lates hypothesized to cause asthma and aller-
gies exist in our common and occupational
environments.
Emission. Little is known about the emis-
sion rates of phthalates from interior surface
materials in normal indoor environmental con-
ditions. Øie et al. (1997) found that phthalates,
including DEHP, migrate from PVC tiles to
house dust, and inhalation of particles contain-
ing phthalates is a plausible route of exposure,
especially among children. Heating or burning
PVC materials releases phthalates and other
combustion products into indoor and ambient
air, as shown in studies on meat wrapper’s
asthma. There is evidence that dampness
enhances degradation of PVC ﬂooring, result-
ing in indoor air concentrations of 2–32 µg/m3
of 2-ethyl-1-hexanol, a hydrolysis product of
DEHP (Norbäck et al. 2000; Tuomainen et al.
2004). Pyrolysis and dampness-related degrada-
tion of PVC materials also cause emission of
various other chemicals that may inﬂuence air-
way irritation and inﬂammation and increase
risk of asthma and allergies, but unfortunately,
the available studies were unable to separate
these effects from those of phthalates.
Concentrations. Only a few studies exam-
ined indoor air and home dust concentrations
of phthalates. Øie et al. (1997) reported that
DEHP is the predominant phthalate species in
both total suspended dust (mean, 64 µg/
100 mg; range, 10–161 µg/100 mg) and
organic fraction (82 µg/100 mg; range,
11–210 µg/100 mg) in homes of children
0–2 years of age. In the 38 samples of sedi-
mented dust, DEHP accounted for 32–97%
(mean, 69%) of the total amounts of phthalates
in total dust. Øie et al. (1997) inferred that
inhalation of aerosols of DEHP adsorbed to
particulate matter is as important as, or more
important than, vapor-phase exposure. As part
of the case–control study, Bornehag et al.
(2004b) reported concentrations of six phtha-
lates in house dust. The median concentration
of DEHP was 0.770 mg/g dust (mean,
1.310 mg/g). Adibi et al. (2003) measured lev-
els of phthalates in 48-hr personal air samples
collected from homes of pregnant women in
New York, New York, and Krakow, Poland.
The range of DEHP was 0.05–0.41 µg/m3
(mean ± SD, 0.22 ± 0.10 µg/m3) in New York
and 0.08–1.1 µg/m3 (0.43 ± 0.24 µg/m3) in
Krakow. Nielsen et al. (1989) reported DEHP
concentrations in different work sites in the
polyvinyl processing industry ranging from 20
to 2,000 µg/m3.
Exposure. Inhalation exposure of phtha-
lates may be assessed directly from air in the
breathing zone, or indirectly from house dust
or by analysis of urinary biomarkers, but
information on indoor air concentrations of
phthalates is limited. Wormuth et al. (2006)
presented scenario-based estimates of overall
exposure to eight phthalates in the general
population. Exposure to DEHP is mainly
from the diet, particularly fatty foods (e.g.,
dairy, ﬁsh, oils), from consumer products and
medical procedures, and to a minor extent, by
inhalation, via indoor air and household dust.
In occupational settings, the inhalation of
phthalates via fumes from heated PVC most
likely constitutes a comparatively larger frac-
tion of exposure for workers.
Effects. Laboratory experiments in mice
have demonstrated that phthalate compounds
exert a modulatory effect on the immune
response to exposure to a coallergen (Hansen
et al. 2007; Larsen et al. 2001a, 2001b, 2002,
2003).
There is evidence that occupational expo-
sures to pyrolysis products of phthalate and
other combustion products increase the risk
of asthma. Case reports identiﬁed and veriﬁed
cases of asthma that were very likely caused by
fumes from hot-wire cutting of PVC ﬁlm or
in combination with fumes from thermo-
activated price labels [Appendix Table A;
available online in Supplemental Material
(http://www.ehponline.org/members/2008/
10846/suppl.pdf)]. These reports also provide
evidence that strong work-related respiratory
symptoms may be experienced without spe-
ciﬁc airway reactivity to these fumes.
Results of the epidemiologic studies in
adults (Table 1) are consistent with case reports
on the effects of PVC film fumes on asthma
and respiratory symptoms. Furthermore, epi-
demiologic studies in adults provide some evi-
dence of a relation between interior PVC
surface materials and the risk of asthma.
Findings on effects on lung function are con-
tradictory; in a study of 240 adult Third
National Health and Nutrition Examination
Survey participants, Hoppin et al. (2004)
showed an association between urinary mono-
butyl phthalate levels and decrements of FVC,
FEV1, and peak expiratory ﬂow measurements,
and between monoethyl phthalate levels and
decrements of FVC and FEV1, among men
but not among women. MEHP levels were not
associated with any of the pulmonary function
parameters.
There is suggestive evidence of the role of
dampness as an inducer of PVC degradation
and emissions of 2-ethyl-1-hexano, although
no bronchial reactivity to PVC was shown by
a single human experiment (Tuomainen et al.
2006). The epidemiologic studies in children
show an association between presence of PVC
surface materials in the home and risk of
asthma and allergies (Table 2). A recent case–
control study among Bulgarian children 
provides further evidence for a relation
between DEHP concentration in house dust
and the risk of wheezing, rhinitis, and/or
asthma (Kolarik et al. 2007).
Summary and future research. Some evi-
dence supports the hypothesis that phthalate
emissions from PVC materials increase the risk
of asthma and allergies. High levels of phtha-
lates from PVC products can modulate the
murine immune response to a coallergen.
Heated PVC fumes possibly contribute to
development of asthma in adults. Epidemio-
logic studies in children show associations
between indicators of phthalate exposure in the
home and risk of asthma and allergies.
This putative association between PVC
and risk to health is potentially very important
from both public and occupational health per-
spectives. However, we need greater under-
standing of the factors that may cause PVC
materials to induce human adverse effects.
Research is required in several areas to
gain insight into the mechanisms of emission,
exposure, and toxicity of the chemical species
released from PVC materials. In brief, it
would be beneﬁcial to improve knowledge of
the following:
• Emission rates and migration of phthalates
from different types of PVC surface materi-
als. This would enable those with high emis-
sion rates to be eliminated from the market.
• The inﬂuence of dampness and temperature
on degradation of PVC materials. Product
design may enhance the effects of dampness
on PVC materials, or the presence of PVC
materials may enhance microbial growth in
indoor surfaces, either of which may inﬂu-
ence human exposure.
• Investigation of relationship of doses used in
animal experiments with human exposures.
Recent inhalation studies in mice have cor-
related experimental exposures with esti-
mated human exposures (Hansen et al.
2007; Larsen et al. 2004, 2007). Their con-
clusion was that nonoccupational human
exposures to DEHP are unlikely to cause an
adjuvant effect or allergic inflammation in
the lung. Additional mechanistic studies, in
association with human exposures, are
required to support these ﬁndings.
• Migration of phthalates into house dust and
resuspension of phthalate-containing parti-
cles into breathing zone.
• Monitoring effects of methods to reduce
indoor exposure, for example, by vacuum
cleaning and by increasing air change, and
use of fume protective masks in occupations.
• Immunomodulatory effects of phthalates in
humans. Effects of short-term inhalation
exposure to phthalates from PVC materials
could be studied in controlled chamber
studies, as demonstrated by Tuomainen
et al. (2006). Such studies could be used to
develop biomarkers of exposure and early
Jaakkola and Knight
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• The effects of exposure to phthalates in
homes and work places on the risk of asthma
and allergies, both in children and in adults,
by conducting large-scale epidemiologic
studies, preferably population-based cohort
and incident case–control studies in different
populations and housing conditions.
•Genetic susceptibility to the effects of
phthalates on asthma and allergies, by inte-
grating assessments of gene–environment
interactions in epidemiologic studies.
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